| |
|
Global Hep Summit Toronto - Real-World Data on Safety and Effectiveness of Glecaprevir/Pibrentasvir for the Treatment of Patients With Chronic Hepatitis C Virus Infection:
Latest Results From the German Hepatitis C-Registry
|
| |
| |
Reported by Jules Levin
16th Annual International Symposium on Viral Hepatitis and Liver Disease's Global Hepatitis Summit, 14-17 June 2018, Toronto, Canada
Markus Cornberg1, Uwe Naumann2, Albrecht Stoehr3, Christoph Sick4, Gerlinde Teuber5, Willibold Schiff elholz6, Stefan Mauss7, Kristi na Lohmann8, Henning Kleine8, Andreas Pangerl8, Tobias Muller9
1Medizinische Hochschule Hannover, Klinik fur Gastroenterologie, Hepatologie und Endokrinologie, Hannover, Germany; 2UBN-Praxis, Berlin, Germany; 3IFI Studien und Projekte GmbH, Hamburg, Germany; 4Praxisonkologie Bremen, Bremen, Germany; 5Practi ce PD Dr. med. G. Teuber, Frankfurt am Main, Germany; 6Gastroenterologische Schwerpunktpraxis, Augsburg, Germany;
7Center for HIV and Hepatogastroenterology, Dusseldorf, Germany; 8AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany; 9Charite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, and Berlin Institute of Health, Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Campus Virchow Klinikum, Berlin, Germany
| |
| |
| |
|
|
|
